Insulet boosts guidance in Q1 update as it grapples with recall saga
Insulet is upping its guidance after a strong first quarter, though ongoing recalls continue to cast a shadow for investors.
Insulet is upping its guidance after a strong first quarter, though ongoing recalls continue to cast a shadow for investors.
A compact weekly email covering company moves, product signals, regulatory updates, and notable funding.